| Date Filed | Type | Description |
| 10/03/2023 |
4
| Mertens Steve (Chief Technology Officer) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 252 shares
@ $0.8904, valued at
$224.4 |
|
| 10/03/2023 |
4
| Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 90 shares
@ $0.8904, valued at
$80.1 |
|
| 10/03/2023 |
4
| Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 2,239 shares
@ $0.8904, valued at
$2k
|
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| Mertens Steve (Chief Technology Officer) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 252 shares
@ $1.2, valued at
$302.4 |
|
| 07/05/2023 |
4
| Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 90 shares
@ $1.2, valued at
$108 |
|
| 07/05/2023 |
4
| Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 2,239 shares
@ $1.2, valued at
$2.7k
|
|
| 06/01/2023 |
4
| Mertens Steve (Chief Technology Officer) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 252 shares
@ $1.21, valued at
$304.9 |
|
| 06/01/2023 |
4
| Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 90 shares
@ $1.21, valued at
$108.9 |
|
| 06/01/2023 |
4
| Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 2,239 shares
@ $1.21, valued at
$2.7k
|
|
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Mertens Steve (Chief Technology Officer) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 252 shares
@ $1.61, valued at
$405.7 |
|
| 04/04/2023 |
4
| Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 90 shares
@ $1.61, valued at
$144.9 |
|
| 04/04/2023 |
4
| Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 2,239 shares
@ $1.61, valued at
$3.6k
|
|
| 03/24/2023 |
4
| Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Sold 2,122 shares
@ $1.6048, valued at
$3.4k
Sold 11,667 shares
@ $1.5085, valued at
$17.6k
Sold 12,711 shares
@ $1.502, valued at
$19.1k
|
|
| 03/20/2023 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Granted 20,576 shares
@ $0
Granted 18,927 options to buy
@ $1.62, valued at
$30.7k
|
|
| 03/20/2023 |
4
| BUCKMAN PAUL (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Granted 20,576 shares
@ $0
Granted 18,927 options to buy
@ $1.62, valued at
$30.7k
|
|
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2023 |
4
| Mertens Steve (Chief Technology Officer) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 6,054 shares
@ $1.47, valued at
$8.9k
|
|
| 02/07/2023 |
4
| Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 2,175 shares
@ $1.47, valued at
$3.2k
|
|
| 02/07/2023 |
4
| Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 53,750 shares
@ $1.47, valued at
$79k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Granted 29,240 shares
@ $0
Granted 29,230 options to buy
@ $1.14, valued at
$33.3k
|
|
| 06/02/2022 |
4
| BUCKMAN PAUL (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Granted 29,240 shares
@ $0
Granted 29,230 options to buy
@ $1.14, valued at
$33.3k
|
|
| 06/02/2022 |
4
| Andrle Edward (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Granted 29,240 shares
@ $0
Granted 29,230 options to buy
@ $1.14, valued at
$33.3k
|
|
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Granted 250,000 shares
@ $0 |
|
|